Generic Drug Maker Agrees To $200 Million Settlement With End Payers In MDL
PHILADELPHIA — End-payer plaintiffs (EPPs) in the generic drug pricing antitrust multidistrict litigation pending in a Pennsylvania federal court on Sept. 3 moved for preliminary approval of a settlement for up...To view the full article, register now.
Already a subscriber? Click here to view full article